Profile: BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer & benign diseases using heat therapy as provided by focused radio frequency & microwave energy. Hyperthermia therapy is a treatment used in battling cancer by heating tumors. The heating is about as warm as a hot tub. Research has shown that heat can damage or kill cancer cells in some tumors while also making radiation therapy more effective in treating some tumors that are recurrent or progressive, despite conventional therapy. The BSD-500 hyperthermia system is approved by the FDA for use alone or in conjunction with radiation therapy in the palliative management of certain solid surface and subsurface malignant tumors (i.e., melanoma, squamous- or basal-cell carcinoma, adenocarcinoma, or sarcoma) that are progressive or recurrent despite conventional therapy. We develop microwave thermal therapy systems for the treatment of symptoms associated with enlarged prostate, a health condition affecting half of men over age 50.

The company was founded in 1978, has revenues of USD 1-5 Million, has ~40 employees and is ISO 9000, ISO 9001, ISO 9002, ISO 9003, CE certified. NASDAQ:BSDM (SEC Filings)

FDA Registration Number: 1719106